DavidCollierMD

PubMed

• Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.
  Ran Jin, Silvia Kruppert, Florian Scholz, Isabelle Bardoulat, Khalil Karzazi, Francois Morand, Greg Kricorian, David Collier, Jonathan Kay> ;Rheumatology and Therapy. 2024 Mar 4
• 2 citations
  Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
  Philip J Mease, Jacqueline O'Brien, Nicole Middaugh, Gregory Kricorian, Scott Stryker, David H Collier, Alexis Ogdie> ;ACR Open Rheumatology. 2023 Aug 1
• Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry.
  Colleen K Correll, Scott Stryker, David Collier, Thomas A Phillips, Anne C Dennos, Stephen J Balevic, Timothy Beukelman> ;RMD Open. 2023 May 1
• Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SE...
  Jeffrey R Curtis, Bradley Stolshek, Paul Emery, Boulos Haraoui, Elaine Karis, Greg Kricorian, David H Collier, Priscilla K Yen, Vivian P Bykerk> ;Journal of Clinical Rheumatology. 2023 Jan 1
• 5 citations
  The Economic Benefit of Remission for Patients with Rheumatoid Arthritis.
  Jeffrey R Curtis, Kathleen M Fox, Fenglong Xie, Yujie Su, David Collier, Cassie Clinton, Hafiz Oko-Osi> ;Rheumatology and Therapy. 2022 Oct 1
• 7 citations
  Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial.
  Philip J Mease, Dafna D Gladman, Joseph F Merola, Atul Deodhar, Alexis Ogdie, David H Collier, Lyrica Liu, Arthur Kavanaugh> ;The Journal of Rheumatology. 2022 Aug 1
• 2 citations
  Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial.
  Philip S Helliwell, Phillip J Mease, Arthur Kavanaugh, Laura C Coates, Alexis Ogdie, Atul Deodhar, Vibeke Strand, Gregory Kricorian, Lyrica X H Liu, David Collier, Daf...> ;RMD Open. 2022 Jul 1
• 11 citations
  Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis.
  Elizabeth A Holdsworth, Bethany Donaghy, Kathleen M. Fox, Pooja Desai, David H. Collier, Daniel E. Furst> ;Rheumatology and Therapy. 2021 Sep 2
• 8 citations
  Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in...
  Philip J. Mease, Scott Stryker, Mei Liu, Bob Salim, Sabrina Rebello, Mahdi Gharaibeh, David H. Collier> ;Arthritis Research & Therapy. 2021 Sep 1
• 3 citations
  Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
  Timothy Beukelman, Aimee Lougee, Roland A. Matsouaka, David H. Collier, Dax G. Rumsey, Jennifer Schenfeld, Scott Stryker, Marinka Twilt, Yukiko Kimura> ;Pediatric Rheumatology Online Journal. 2021 Aug 21
• 12 citations
  Juvenile Spondyloarthritis in the CARRA Registry: High Biologic Use, Low Prevalence of HLA‐B27, and Equal Sex Representation in Sacroiliitis
  Dax G. Rumsey, Aimee Lougee, Roland A. Matsouaka, David H. Collier, Laura E. Schanberg, Jennifer Schenfeld, Natalie J. Shiff, Scott Stryker, Pamela F. Weiss, Timothy B...> ;Arthritis Care & Research. 2021 Jul 1
• 2 citations
  Potential for Major Therapeutic Changes to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans With R...
  Brian C. Sauer, Wei Chen, Jincheng Shen, Neil A. Accortt, David H. Collier, Grant W. Cannon> ;Arthritis Care & Research. 2021 Jun 9
• 8 citations
  Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis.
  Laura C. Coates, Joseph F. Merola, Philip J. Mease, Alexis Ogdie, Dafna D. Gladman, Vibeke Strand, Leonieke J J van Mens, Lyrica Liu, Priscilla K Yen, David H. Collier...> ;Rheumatology. 2021 Mar 2
• 1 citations
  Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination
  Vibeke Strand, Philip J. Mease, Ervant J Maksabedian Hernandez, Bradley S. Stolshek, Lyrica Liu, David H. Collier, Gregory Kricorian, Joseph F. Merola> ;RMD Open. 2021 Jan 1
• Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis.
  Brian C. Sauer, Wei Chen, Yizhe Xu, Jincheng Shen, Neil A. Accortt, David H. Collier, Grant W. Cannon> ;Arthritis Research & Therapy. 2020 Oct 22
• 3 citations
  The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
  Devin Incerti, Ervant J Maksabedian Hernandez, Joseph Tkacz, Jeroen P. Jansen, David H. Collier, Mahdi Gharaibeh, L. Moore-Schiltz, Bradley S. Stolshek> ;Journal of Managed Care & Specialty Pharmacy. 2020 Sep 30
• 1 citations
  Reply to Letter to the Editor on Mease et al
  Philip J. Mease, David H. Collier, Gregory Kricorian, James B. Chung> ;Arthritis & Rheumatology. 2020 Apr 7
• 7 citations
  Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate.
  Joseph Tkacz, Mahdi Gharaibeh, Kathryn DeYoung, Kathleen Wilson, David H. Collier, Hafiz Oko-Osi> ;Journal of Managed Care & Specialty Pharmacy. 2020 Feb 27
• 1 citations
  Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept
  Machaon Bonafede, Hafiz Oko-Osi, Mahdi Gharaibeh, Janna Manjelievskaia, Lorena Lopez-Gonzalez, David H. Collier, Bradley S. Stolshek> ;Journal of Managed Care & Specialty Pharmacy. 2020 Feb 1
• 5 citations
  The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
  Nancy A. Shadick, Nicole M. Gerlanc, Michelle L. Frits, Bradley S. Stolshek, Brenna L. Brady, Christine Iannaccone, David H. Collier, Jing Cui, Alex Mutebi, Michael E....> ;Clinical Rheumatology. 2019 Jul 29
• 6 citations
  Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis...
  Philip J. Mease, Neil A. Accortt, Sabrina Rebello, Carol J. Etzel, Ryan W. Harrison, Girish A. Aras, Mahdi Gharaibeh, Jeff Greenberg, David H. Collier> ;Rheumatology International. 2019 Jul 18
• 2 citations
  Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) re...
  Stever, Grant W. Cannon, Chia-Chen Teng, Neil A. Accortt, David H. Collier, Brian C. Sauer> ;Clinical and Experimental Rheumatology. 2019 Jul 1
• 140 citations
  Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial
  Philip J. Mease, Dafna D. Gladman, David H. Collier, Christopher T. Ritchlin, Philip S. Helliwell, Lyrica Liu, Gregory Kricorian, James B. Chung> ;Arthritis & Rheumatology. 2019 Jul 1
• 3 citations
  Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study.
  Grant W. Cannon, Alan R Erickson, Chia-Chen Teng, Tina Huynh, Sharon D. Austin, Sally W. Wade, Bradley S. Stolshek, David H. Collier, Alex Mutebi, Brian C. Sauer> ;Rheumatology Advances in Practice. 2019 Jan 1
• 5 citations
  Defining and characterizing sustained remission in patients with rheumatoid arthritis
  Jeffrey R. Curtis, Mona Trivedi, Boulos Haraoui, Paul Emery, Grace S. Park, David H. Collier, Girish A. Aras, James B. Chung> ;Clinical Rheumatology. 2018 Apr 1
• Join now to see all

Journal Articles

• Anti-collagen antibodies and immune response gene products in rheumatoid arthritis.  
  Collier DH, Kerwar SS, Garovoy MR, Fye KH, Stobo JD, Arthritis Rheum 27(11):1201-1209
• Hypothesis: The nervous system may contribute to the pathogenesis of rheumatoid arthritis.  
  Levine JD, Collier DH, Basbaum AI, Moskowitz MA, Helms CA, J Rheumatol 12(3):406-411
• mmunoglobulin G heavy-chain (Gm) allotypes and the immune response to types I and II collagen in rheumatoid arthritis.  
  Collier DH, Schanfield MS, Kerwar SS, Stobo JD, Disease Markers 3(2):91-102
• Hypertrophic osteoarthropathy associated with achalasia.  
  Collier DH, Zulman JI, Am J Med 81(2):355-362
• Diet and arthritis.  
  Collier DH, Consultant 29(5):63-78
• Skin thickness score in systemic sclerosis (SSc): an assessment of interobserver variability in three independent studies.  
  Clements PJ, Lachenbruch PA, Siebold JR, Zee B, Steen VD, Brennan P, Silman A, Allegar N, Varga J, Massa M, Wigley FM, Ingenito F, Weisman M, Needleman B, Martin RW, M..., J Rheumatol 20:1892-1896
• Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.  
  Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D, Wigley F, Medsger T, Steen V, Moreland L, Dixon M, Massa..., J Rheumatol 22:1281-1285
• Scleroderma: cholesterol crystals and delayed wound healing.  
  Wolf T, Eckhoff D, Collier D, Journal of Orthopaedic Rheumatology 9:60-63
• Carpal tunnel syndrome and shoulder pain with particular attention to diabetic patients.  
  Cohen JA, Collier DH, Gross KF, The Permanente Journal 1:26-28
• Oral Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study.  
  Wigley FM, Korn JH, Csuka ME, Medsger TA, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Menkel PA, Gruber B, Kaufman L, Va..., Arthritis Rheum 41(4):670-677
• High-dose (HI-DPA) vs. low-dose (LO-DPA) penicillamine in early diffuse systemic sclerosis (SSc) trial: Analysis of trial.  
  Clements PJ, Furst DE, Wong WK, Mayes MD, White B, Wigley F, Weisman WH, Barr W, Moreland LW, Medsgar TA, Steen V, Martin RW, Collier DH, Weinstein A, Lally E, Varga J..., Arthritis Rheum 42(6):1194-1203
• Correlates of the disability index of the health assessment questionnaire - A measure of functional impairment in systemic sclerosis.  
  Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin R, Collier DH, Weinstein A, Lally E,..., Arthritis Rheum 42(11):2372-2380
• Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.  
  Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier DH, Wigley FM, Merkel PA, Csuka ME, Hsu U, Rocco S..., Ann Intern Med 132:871-879
• Three generations of patients with lupus erythematosus and hereditary angioedema.  
  Pacheco TR, Weston WL, Giclas PC, Collier DH, Lee LA, Am J Med 109:256-257
• Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.  
  Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martain RW, Collier DH, Weinstein A, Lal..., Arthritis Rheum 43:2445-2454
• The disability index of the health assessment questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosi...  
  Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E,..., Arthritis Rheum 44(3):653-661
• Effects of the American College of Rheumatology systemic sclerosis trial - guidelines on the nature of systemic sclerosis patients entering a clinical trial.  
  Furst DE, Clements PJ, Wong WK, Mayes MD, Wigley F, White B, Weisman M, Barr W, Moreland L, Martin R, Medsger TA, Steen V, Collier D, Weinstein A, Lally E, Varga J, We..., Rheumatology 40:615-622
• Fibromyalgia: diagnosis and treatment.  
  Ferucci E, Collier DH, Primary Care Case Reviews 5:101-108
• Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon.  
  Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsgar TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jim..., Arthritis Rheum 46(9):2410-2420
• Scleroderma-associated pulmonary hypertension: who’s at risk and why.  
  Fagan KA, Collier DH, Badesch DB, Advances in Pulmonary Hypertension 1(2):5-9
• Predictions and outcomes in scleroderma renal crisis. The high-dose versus low-does D-Penicillamine in early diffuse systemic sclerosis trial.  
  DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WW, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein..., Arthritis Rheum 46(11):2983-2989
• Scleroderma and pulmonary hypertension - Esclerodermia e hipertensâ pulmonar.  
  Fagan KA, Collier DH, Badesch DB, Rev Bras Rheumatol 43(5):294-301
• High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.  
  Clement PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier DH, Weinstein A, Lally E, Varga J..., Semin Arthritis Rheum 33:249-263
• The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concern over the use of total-body irradiation in systemic sclerosis.  
  Burt RK, Kallunian K, Patel D, Thomas J, Yeager A, Traynor A, Heipe F, Arnold R, Marmont A, Collier D, Glatstein E, Snowden J, Bone Marrow Transplant 34:745-751
• Responsiveness of the SF-36 and health assessment questionnaire disability index (HAQ-DI) in a systemic sclerosis clinical trial.  
  Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FW, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier D,..., J Rheumatol 32:832-40
• Join now to see all

Books/Book Chapters

• Rheumatology Secrets. 
  Chapter: Reflex sympathetic dystrophy syndrome 
  Page 382 - 388Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Rheumatology Secrets. 
  Chapter: Nonsteroidal anti-inflammatory drugs 
  Page 465 - 472Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Geriatric Medicine. 
  Chapter: Musculoskeletal diseases 
  Collier DH, Arend WPEditors: Jahnigen D, Schrier RW.Blackwell Science, CambridgeEdition 2,
• Primary Care Secrets. 
  Chapter: Monarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 2,
• Primary Care Secrets. 
  Chapter: Polyarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 2,
• Rheumatology Secrets. 
  Chapter: Systemic sclerosis 
  Page 151 - 160Collier DHEditors: West SG.Hanley & Belfus, Inc, PhiladelphiaEdition 2,
• Rheumatology Secrets. 
  Chapter: Complex regional pain syndrome (reflex sympathetic dystrophy syndrome) 
  Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Rheumatology Secrets. 
  Chapter: Nonsteroidal anti-inflammatory drugs (NSAIDs) 
  Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Primary Care Case. 
  Chapter: romyalgia: diagnosis and treatment 
  Ferucci E, Collier DH
• Advances in Pulmonary Hypertension. 
  Chapter: Scleroderma-associated pulmonary hypertension: who’s at risk and why 
  Fagan KA, Collier DH, Badesch DB
• Primary Care Secrets. 
  Chapter: Monarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 3,
• Primary Care Secrets. 
  Chapter: Polyarticular arthritis 
  Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, PhiladelphiaEdition 3,
• Medicine: Diagnosis and Treatment. 
  Chapter: Rheumatology and immunology 
  Page 399 - 445Collier DH, Steigerwald JCEditors: Schrier RW.Little, Brown and Co, Boston
• Clinical Internal Medicine in the Aged. 
  Chapter: Musculoskeletal diseases in the elderly 
  Arend WP, Harmon CE, Collier DHEditors: WB Saunders.Schrier RW, PhiladelphiaEdition 2,
• Primary Care Secrets. 
  Chapter: Monoarticular arthritis 
  Page 273 - 276Collier DHEditors: Mladenovic J.Hanley & Belfus, Inc, Philadelphia
• Rheumatology Secrets. 
  Chapter: Systemic sclerosis 
  Collier DHEditors: West SG.Hanley & Belfus, Inc, Philadelphia
• Join now to see all

Abstracts/Posters

• Multivariate analysis of spinal and peripheral mineral loss in patients with rheuma¬toid arthritis.
  Collier DH, Cann CE, Fye KH, Riccardi PR, Genant HK, Arthritis Rheum 25(4):537
• The association between collagen antibodies and human Ia molecules.
  Collier DH, Kerwar S, Stobo JD, Arthritis Rheum 26(4):S20
• The role of the peripheral nervous system in experimental arthritis.
  Collier DH, Achten MI, Levine JD, Arthritis Rheum 27(4):S22
• Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to collagen in rheumatoid arthritis (RA).
  Collier DH, Kerwar SS, Stobo JD, Schanfield MS, Clinical Research 33(1):98A
• The neuro¬peptide substance P (SP) causes shape change and adhesion in human polymor¬phonuclear leukocytes (PMN).
  Collier DH, Achten MI, Henson J, Henson P, Arend WP, Arthritis Rheum 29(1):S26
• Significantly abnormal anti-double stranded DNA (anti-DNA) levels have seasonal variation.
  Collier DH, Levin MJ, Arthritis Rheum 30:S87
• Ipsilateral shoulder pain (SP) in carpal tunnel syndrome (CTS).
  Becker JR, Cohen JA, Collier DH, Arthritis Rheum 31(Sup):R25
• Autonomic nervous system (ANS) dysfunction in scleroderma.
  Collier DH, O'Rourke BH, Cohen JA, Arthritis Rheum 32:S35
• Autonomic nervous system dysfunction in patients with scleroderma.
  Cain WJ, Cohen JA, Collier DH, Clinical Research 38:111A
• Prevalence of antibodies to cardiolipin in rheumatic diseases detected by a standardized enzyme immunoassay.
  Lopez LR, Peterson MJ, Sauer NK, Hites MJ, Collier DH, Enzenauer RJ, Clin Exp Rheum 8:215
• IgA anticardiolipin antibody associated with interstitial lung disease in systemic sclerosis.
  Collier DH, Enzenauer RJ, Santos M, West S, Lopez L, Arthritis Rheum 35:S346
• Neutrophil influx and retention in the lung in systemic sclerosis: a scintographic study.
  Mortenson RL, King TE, Young SK, Ikle D, Collier D, Worthen GS, Am Rev Respir Dis 147:A490
• Pulmonary hypertension in systemic sclerosis: identification by doppler echocardiogram and clinical features.
  Spencer RT, Turkevich, D, Groves BM, Collier DH, Arthritis Rheum 36:S132
• Clinical utility of serum hyaluronic acid levels in liver disease.
  Santos M, Kondo T, Wieczorek A, Collier D, Lopez L, Clinical Chemistry 41:S71
• Protein C, protein S, and free protein S levels in patients with liver disease measured by ELISA.
  Butler M, Santos M, Collier D, Lopez L, Clinical Chemistry 41:S170
• Acute hemodynamic response to IV Iloprost or prostacycline (PGI2) in patients with pulmonary hypertension associated with systemic sclerosis and other collagen vascula...
  Heller JM, Spencer RT, Collier DH, Badesch DB, Groves BM, Arthritis Rheum 39:S151
• Controlled trial of recombinant human relaxin (rhRlxn) in diffuse scleroderma (DS).
  Seibold JR, Korn J, Simms R, Clements PJ, Moreland L, Mayes MD, Furst DE, Rothfield N, Steen U, Weisman M, DeMarco P, Collier D, Wigley F, Merkel PA, Csuka ME, Rocco S..., Arthritis Rheum 40:S123
• High-dose (HI-DPA) vs low dose (LO-DPA) penicillamine in early diffuse systemic sclerosis (SSc) trial: Analysis of trial.
  Clements PJ, Wong WK, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Weinstein A, Medsger T, Steen U, Martin R, Moreland L, Collier D, Lally E, V..., Arthritis Rheum 40:S173
• US phase III trial of relaxin in diffuse scleroderma.
  Seibold JR, Clements PJ, Korn JH, Ellman M, Rothfield NF, Wigley Fm, Moreland LW, Kim Y, Silver RM, Furst DE, Steen VD, Firestein GS, Kavanaugh AF, Mayes MD, Collier D..., J Rheumatol 28 (S63):55
• Diaphragmatic dysfunction is a cause of dyspnea and restrictive pulmonary physiology in patients with systemic sclerosis (SSc).
  Hirsh J, Collier D, Brown K, Arthritis Rheum 44:S132
• Safety and Tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud’s phenomenon.
  Sule SD, Hummers L, Shapiro L, Fiorentino D, Chung L, Baron M, Shanahan J, Hsu V, Rothfield N, Steen V, Martin R, Dugawson C, Smith E, Mayes M, Simms R, Pope J, Kaha..., Arthritis Rheum 56:S62
• A multi-center placebo-controlled “in-life” study of MQX-503 in patients with Raynaud’s phenomenon.
  Chung L, Baron M, Collier D, Csuka ME, Fiorentino D, Gruber B, Hsu V, Kahaleh B, Martin R, Mayes M, Pope J, Rothfield N, Shanahan J, Shapiro L, Simms R, Smith E, Stee..., Arthritis Rheum 56:S824
• MQX-503, a movel topical nitroglycerin formulation, improves severity of Raynaud phenomenon in a heterogeneous patient population.
  Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin R, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B,..., Arthritis Rheum 56:S825
• Gastric antral vascular ectasia (GAVE) in patients with systemic sclerosis (SSc): a systematic review of the literature.
  Davis L, Collier D, Caplan L, Arthritis Rheum 56:S484
• Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud’s phenomenon.
  Rothfield N, Shapiro L, Fiorentino D, Chung L, Denton C, Herrick A, Baron M, Shanahan J, Hsu V, Belch J, Steen V, Scheja A, Martin R, Smith E, Mayes M, Simms R, Pope J..., Arhtirits Rheum 58:S821
• Join now to see all

Lectures

• Multivariate analysis of spinal and peripheral mineral loss in patients with rheumatoid arthritis. 
  Pan-American Congress of Rheumatology, Washington, D. C
• Class II antigen MT3 association with rheumatoid arthritis. 
  Eleventh ARA Western Regional Meeting, Monterey, California
• The association between collagen antibodies and human Ia molecules. 
  Forty-Seventh Annual Scientific Meeting of the American Rheumatism Association, San Antonio, Texas
• The role of the peripheral nervous system in experimental arthritis. 
  Forty-Eighth Annual Scientific Meeting of the American Rheumatism Association, Minneapolis, Minnesot
• The neuropeptide substance P causes shape change and adhesion in human polymorphonuclear leukocytes. 
  Fourteenth ARA Western Regional Meeting, Oakland, California
• Significantly abnormal anti-double stranded DNA (anti-DNA) levels have seasonal variation. 
  Fifty-First Annual Scientific Meeting of the American Rheumatism Associa¬tion, Washington, D. C
• Significantly abnormal anti-double stranded DNA (anti-DNA) levels have seasonal variation. 
  Seventh Annual Epidemiological Research Exchange, University of Colorado School of Medicine
• Ipsilateral shoulder pain in carpal tunnel syndrome. 
  Fifty-Second Annual Scientific Meeting of the American Rheumatism Association, Houston, Texas
• Autonomic nervous system dysfunction in scleroderma. 
  Fifty-Third Annual Scientific Meeting of the American College of Rheumatol¬ogy, Cincinnati, Ohio
• Controlled epidemiologic survey of toxic exposure in patients with systemic sclerosis. 
  Tenth Annual Epidemiological Research Exchange, University of Colorado School of Medicine, Denver
• IgA anticardiolipin antibody associated with interstitial lung disease in systemic sclerosis. 
  Fifth International Symposium on Antiphospholipid Antibodies, San Antonio, Texas
• The role of the neuropeptide substance P in experimental arthritis. 
  Arizona State University, Tempe, Arizona
• Reflex sympathetic dystrophy. 
  William Beaumont Army Medical Center, El Paso, Texas
• Pathophysiologic approach to reflex sympathetic dystrophy. 
  Eleventh Annual Rheumatology on the Beach, Destin, Florida
• Review of clinical rheumatology, laboratory tests in rheumatology, and therapeutic management in the United States. 
  Bach Mai Hospital, Hanoi, Vietnam
• Complex regional pain syndrome (reflex sympathetic dystrophy). 
  Mississippi Pain Society, Jackson, Mississippi
• ACR/ARHP Combined Clinical Symposium: Practical management of common hand problems, with Pamela B. Harrell, OTR, CHT. 
  1998 ACR/ARHP National Scientific Meeting, San Diego, California
• Non-operative and medical management of osteoarthritis. 
  University of Arizona,Phoenix, Arizona
• New treatments in the management of osteoarthritis. 
  Rocky Mountain Rheumatism Society, Denver, Colorado
• Non-Operative and medical management of osteoarthritis. 
  University of Arizona, St. Joseph’s Hospital and the Institute for Bone and Joint Disorder sponsored
• Scleroderma from a rheumatologist’s perspective. 
  Medicis Winter Skin Seminar, Snowmass, CO
• Radiology of common rheumatic diseases. 
  Seventh Annual Rheumatology and Musculoskeletal Disease Conference, Rose Medical Center
• Soft tissue rheumatism. 
  University of Colorado School of Medicine, YMCA Conference Center, Estes Park, Colorado
• Septic arthritis, crystal-induced arthritis, and seronegative spondyloarthropathies. 
  Fourth Annual Internal Medicine Board Review Course, University of Colorado School of Medicine
• Treatment of rheumatoid arthritis. 
  Thirty-Third Annual Family Practice Review, University of Colorado School of Medicine, Denver
• Join now to see all